CPC A61K 31/485 (2013.01) [C07D 211/62 (2013.01); C07D 217/04 (2013.01); C07D 221/22 (2013.01); C07D 221/28 (2013.01); C07D 223/04 (2013.01); C07D 401/12 (2013.01); C07D 405/12 (2013.01); C07D 489/00 (2013.01); C07D 489/09 (2013.01)] | 15 Claims |
1. A method of treating a depressive symptom in a subject comprising administering to the subject a compound selected from:
![]() ![]() ![]() or a pharmaceutically acceptable salt thereof;
wherein the depressive symptom is depressed mood, loss of pleasure, loss of appetite, sleep disturbance, psychomotor changes, fatigue, post-partum depression, associated with a mental condition, acute stress disorder, adjustment disorders with depressed mood, Asperger syndrome, attention deficit, bereavement, bipolar I disorder, bipolar II disorder, borderline and personality disorder, cyclothymia and dysthymia, major depressive disorder (MDD), treatment-resistant disorder (TRD), Dysthymic disorder, hyperactivity disorder, impulse control disorder, mixed mania, obsessive-compulsive personality disorder (OCD), paranoid, post-traumatic stress disorder, seasonal affective disorder, self-injury separation, sleep disorder, substance-induced mood disorder, Tourette syndrome and tic disorder, Trichotillomania, or an anxiety disorder.
|